EyePoint, Inc. is under investigation by Pomerantz LLP for potential securities fraud following two failed Phase 3 clinical trials of its drug Duravyu for wet age-related macular degeneration. The first trial results in August showed the drug did not meet its primary endpoint, causing the stock to drop nearly 67%. The second trial in October also failed, leading to an 85% stock plunge and major cost-cutting including program termination and workforce reduction. Investors are advised to contact the law firm regarding possible claims. This case highlights risks in biotech investments tied to clinical trial outcomes.
EyePoint, Inc. is the subject of an investor alert, and here is Pluang's health sector market snapshot as of Nov 11, 2026 04:52 WIB: Among 150 priced US health stocks, 49 rose and 100 fell. Notably, HIMS fell 17.18% to USD 19.00 with a Pluang order activity split of 41% Sell and 59% Buy, contrasting with WGS which dropped 16.08% to USD 55.15 but had 100% Buy orders. INO also declined 13.91% to USD 1.30, with 28% Sell and 72% Buy activity and the longest typical hold time of 41 days on Pluang.
Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...
Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...
TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...
Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...
OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...
